Anti-MDM2 Antibody

Designed for research workflows that demand reliable detection of the MDM2 oncoprotein, this primary antibody from Antibodies.com is a rabbit polyclonal reagent raised against MDM2 and validated for use in Western blot (WB) and ELISA workflows. Supplied as an unconjugated preparation in a 50 µl format, it is intended for use on human samples and is affinity-purified to deliver batch-to-batch consistency with minimal off-target binding. The unconjugated format gives researchers the flexibility to pair the antibody with their own choice of secondary detection reagent or label, whether for chromogenic, fluorescent or HRP-based readouts. Polyclonal reactivity typically provides broader epitope coverage than monoclonal alternatives, which can be advantageous when probing MDM2 isoforms, post-translational modifications, or low-abundance targets in cell lysates and tissue extracts. For Western blotting, a working concentration in the range commonly recommended for polyclonal anti-MDM2 reagents (around 1 mg/mL stock, diluted appropriately) supports clear band detection, while ELISA protocols benefit from the same polyclonal recognition for quantitative antigen capture. The product is shipped and stored according to the standard Antibodies.com cold-chain protocol — keep refrigerated at 2–8 °C for short-term use and aliquot/freeze at –20 °C for longer-term storage to preserve activity across multiple experiments. With its combination of validated applications, validated host species reactivity, and the quality assurance that comes from the Antibodies.com catalogue, this anti-MDM2 antibody is well suited to p53/MDM2 pathway studies, cancer signalling research, and routine immunoassay development.